HR 5027 · 118th Congress · Health
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2024-12-17)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 5027 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 5027 To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 27, 2023 Mrs. Miller of West Virginia (for herself and Ms. Sewell) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE; TABLE OF CONTENTS. This Act may be cited as the ``Chronic Kidney Disease Improvement in Resea…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (13)
11 Democrats2 Republicans